Transforming growth factor- 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment

By Holland T.A.   Tessmar J.K.V.   Tabata Y.   Mikos A.G.  

Journal of Controlled Release, Vol. 94, Iss. 1, 2004-01 ,pp. : 101-114

Elsevier

Access to resources Recommend Favorite

Anti-inflammatory action of a novel peptide, SEK-1005, isolated from a Streptomyces

By Kuriyama K.   Fujiwara A.   Inagaki K.   Abe Y.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Inhibition of Transforming Growth Factor- &bgr;Activation is a Novel Effect of Chymase Inactivation

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 1, 2005-02 ,pp. : 19-22

Bentham Science Publishers

Access to resources Recommend Favorite

INHIBITION OF WOUND-INDUCED EXPRESSION OF TRANSFORMING GROWTH FACTOR-beta1 mRNA BY ITS ANTISENSE OLIGONUCLEOTIDES

By Kim H.M.   Choi D.H.   Lee Y.M.  

Pharmacological Research, Vol. 37, Iss. 4, 1998-04 ,pp. : 289-293

Academic Press

Access to resources Recommend Favorite

Application of Sustained-release Carrier of NanoAg-Epidermal Growth Factor in Promoting Refractory Diabetic Wound Healing

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 2, 2016-02 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite